AL amyloidosis phase III clinical trial of birtamimab fails to meet primary endpointAL amyloidosisMay 26, 2025
Watch the recording of the EHA 2023 highlights webinarAL amyloidosis, MPE, Myeloma, VideosJuly 10, 2023
Watch the recording of webinar “AL amyloidosis treatment updates and patient experiences”AL amyloidosis, MPEApril 24, 2024
MPE at ASH 2024: key research and expert insights on myelomaAL amyloidosis, CAR-T, Conferences, MPE, MyelomaDecember 16, 2024
MPE webinar on ASH 2024 myeloma and AL amyloidosis highlightsAL amyloidosis, latest, MPE, Myeloma, NewsNovember 29, 2024
Myeloma and AL amyloidosis ASH 2024 previewAccess, AL amyloidosis, CAR-T, MPE, MyelomaNovember 29, 2024
Official launch of EuroBloodNet, the European Reference Network on rare haematological diseasesAL amyloidosis, MyelomaMarch 21, 2017
Takeda announces discontinuation of the phase 3 clinical trial TOURMALINE-AL1 in AL amyloidosisAccess, AL amyloidosisJune 6, 2019
